CD93 and neoplasm: However, recently, Sun et al. showed that the IGFBP7-CD93 axis was related to disordered tumor vasculature, and a CD93-neutralizing antibody could enhance immune response, associated with vascular normalization, increased endothelial activation, and increased leukocyte recruitment [9].